Director of Investor Relations & Corporate Development, Precision Neuroscience
$175-225k
Office located in Manhattan. NY
Building powerful, minimally invasive brain implants
Be an early applicant
Building powerful, minimally invasive brain implants
21-100 employees
Be an early applicant
$175-225k
Office located in Manhattan. NY
21-100 employees
Company mission
To provide breakthrough treatments for the one billion patients worldwide suffering from neurological illnesses.
Role
Who you are
- A minimum of 8 years of progressive experience in a combination of corporate strategy, investor relations, investment banking, equity research, or management consulting
- Direct experience in the biotechnology, medical device, or life sciences industry is essential. Familiarity with neurotechnology is a significant plus
- Exceptional financial modeling, valuation, and analytical skills, with a deep understanding of financial statements and capital markets
- Outstanding written and verbal communication skills, with a proven ability to distill complex scientific and financial information into clear, concise, and compelling messages for diverse audiences
- Excellent project management and organizational skills, with the ability to manage multiple projects simultaneously under tight deadlines
- Strong interpersonal skills and the ability to collaborate effectively across departments and with senior leadership
- Strategic and critical thinker with a high degree of business acumen and the ability to operate at both the strategic and tactical levels
- Proactive, self-motivated, and able to thrive in a fast-paced, dynamic, and mission-driven startup environment
- Bachelor’s degree in Finance, Economics, Life Sciences, or a related field. An MBA or other advanced degree (PhD, MD) is strongly preferred
What the job involves
- We are seeking a dynamic and experienced Director of Investor Relations and Corporate Development to manage investor relations and help shape Precision Neuroscience’s corporate strategy
- This role will lead our investor relations strategy and execution and will be a key contributor to our corporate strategy
- This is a unique opportunity to be part of shaping the strategy for a distributive new category in medical technology
- This position is on-site at our Manhattan office
- To be eligible for this role you must currently be based in the United States, and have working rights
- Develop and execute investor relations strategy aligned with the company’s corporate goals and enhancing its reputation within the financial community
- Craft and maintain a compelling and consistent investment narrative; serve as a key contributor to the company’s external messaging
- Serve as a primary point of contact for the investment community, fostering strong relationships with current and potential investors
- Plan, coordinate, and participate in investor outreach, meetings, diligence responses and other investor activities
- Conduct in-depth market analysis, competitive intelligence, and landscape assessments to identify key industry trends, risks, and opportunities in the BCI and neurotechnology sectors
- Identify and evaluate new growth opportunities, including potential M&A, strategic partnerships, joint ventures, and new market entry
- Develop comprehensive business cases and financial models for strategic initiatives to support executive and board-level decision-making
Our take
Precision Neuroscience is finding new, practical ways of improving the lives of those who are suffering from neurological conditions.
The Layer 7 Cortical Interface is an implant that’s 1/5th the thickness of a human hair and can be fitted onto the human brain without damaging it. Through minimally invasive micro-slit surgery, the brain implant can process data and aims to move brain-computer interfaces (BCI) technology from small-scale research into a new era of worldwide usage.
The long-term goal of the Layer 7 Cortical Interface is to allow customers to interact with people and the world via digital means. Whilst the market is blooming with new companies exploring the possibilities of BCI technology, Precision has an advantage in that its solution requires minimal surgery and is reversible, meaning that it has wider implications than just neurological disorders.
Work is ongoing but with substantial funding behind it, Precision is using its investment to ramp up product development and FDA regulatory review as well as expanding its team.
Freddie
Company Specialist at Welcome to the Jungle
Insights
68% employee growth in 12 months
Company
Funding (last 2 of 4 rounds)
Dec 2024
$102m
SERIES C
Nov 2024
$93m
LATE VC
Total funding: $249m
Company HQ
Kips Bay, New York, NY
Leadership
Michael Mager
(CEO & Co-Founder)Currently Co-Chairman at Assembly Software and Partner at Ridge Road Partners, Board Member at Supply Finance.
Mark Hettick
(Vice President of Engineering - Microfabrication)Previously Process Engineer at Neuralink, Lead Safety Coordinator at Berkeley Labs and Research Assistant at the Joint Center for Artificial Photosynthesis.
Benjamin Rapoport
(Chief Science Officer & Co-Founder)Previously Scientific Director of the BioDesign Program at Mount Sinai Health Systems. Previously Neurosurgery Residency at Weill Cornell Medicine and Founding Member at Neuralink.
Salary benchmarks
We don't have enough data yet to provide salary benchmarks for this role.
Submit your salary to help other candidates with crowdsourced salary estimates.
Share this job
View 9 more jobs at Precision Neuroscience